Goldman Sachs Group Inc Dexcom Inc Put Options Transaction History

Goldman Sachs Group Inc

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $192,000 - $348,180	-3,000 Reduced 16.67%	15,000 $1.01 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $1.65 Million - $2.11 Million	15,000 Added 500.0%	18,000 $2.04 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $411,192 - $504,360	-3,600 Reduced 54.55%	3,000 $416,000
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $498,233 - $819,456	6,600 New	6,600 $818,000
Q2 2023 May 14, 2024	SELL	$112.47 - $130.98 $1.12 Million - $1.31 Million	-10,000 Reduced 20.0%	40,000 $5.14 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $4.5 Million - $5.24 Million	40,000 New	40,000 $5.14 Million
Q2 2022 May 14, 2024	BUY	$67.99 - $132.89 $2.95 Million - $5.77 Million	43,400 Added 657.58%	50,000 $3.73 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $639,106 - $1.25 Million	-9,400 Reduced 15.82%	50,000 $3.73 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $6.05 Million - $7.59 Million	46,600 Added 364.06%	59,400 $31.9 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $1.37 Million - $1.83 Million	12,800 New	12,800 $7 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.